The first vaccine against the Bundibugyo Ebola virus is poised to enter phase 1 clinical trial. The trial will be conducted in the U.K. and will assess the safety and immune response of the vaccine ...
Oxford and Serum Institute have launched the first human trial of a vaccine targeting the deadly Bundibugyo strain of Ebola ...
Smaller doses of COVID-19 booster vaccines can provide long-lasting immunity, helping reduce costs and improve access to ...
July 13 (Reuters) - The University of Oxford has launched the first human trial of a vaccine against Bundibugyo ebolavirus, ...
Smaller doses of COVID-19 booster vaccines can provide long-lasting immunity, helping to reduce costs and improve access to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results